LUMOXITI J Code: J9313
Injection, moxetumomab pasudotox-tdfk, 0.01 mg
Drug & Product Overview
About LUMOXITI
Lumoxiti is a medication aligned to the HCPCS J Code: J9313 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Astrazeneca.
Manufacturers, reach out to us to add more information.
NDC Code Information
1 NDC package is crosswalked to J9313. Package detail is available to logged-in subscribers.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| •••••-••••-•• Log in to view | LUMOXITI | •••••••••••• Log in to view | •••• Log in to view | ••• •• / • •• Log in to view |
LUMOXITI CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug |
| 96415 | Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure) |
CMS has identified Lumoxiti (J9313) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →
LUMOXITI Medically Unlikely Edits (MUE)
The most billing units of J9313 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.01 mg.
MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →
LUMOXITI Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available Lumoxiti billing and coding guide?
Are there any available Lumoxiti patient assistance programs?
Where can I find Lumoxiti prescribing information?
Where can I find Lumoxiti side effect information?
Does billing LUMOXITI require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to LUMOXITI.
